The Sydney Addiction Seminars are back, with our upcoming topic:
Depot Buprenorphine: Will it be a Game Changer?
Face-to-face & webinar tickets available!
Perhaps the greatest disincentive to opioid pharmacotherapy for opioid dependence is the need for supervised dosing, which is inconvenient, time-consuming, expensive and often poorly compatible with life activities that hallmark “recovery”.
Two depot buprenorphine products, Buvidal® (Camurus) and Sublocade® (Indivior) have been submitted for consideration of listing under the Pharmaceutical Benefits Scheme in Australia.
How and when will these treatments be rolled out in Australia? Are there any down sides to this new treatment modality? Will it change people’s preference for treatment medication? How will dose tapering towards eventual “graduation” be accomplished? These and other questions will be dealt with in this seminar.
Course Objectives
At the end of this seminar, the participant will be able to:
Presenters
Join us from 6:30pm for a light evening meal, with the seminar commencing at 7:00pm sharp. The seminar will also be available online to those who select an online webinar ticket, which is generally allocated to those who are outside of the Sydney metropolitan area.
FAQs
What are my transport/parking options for getting to and from the event?
Public Transport
The
Bicycle
Several
Parking
If you require parking we suggest either using the casual parking options on
Taxi
The closest taxi rank is located near the Chris O’Brien Lifehouse on
How can I contact the organiser with any questions?
Give us a call on 02 9515 9811 or email